Evidence map›Paper›PMID 38187374›Full record

ArticleFrontiers in immunology2023

Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC.

Nikolett Gémes, József Á Balog, Patrícia Neuperger, Erzsébet Schlegl, Imre Barta, János Fillinger, Balázs Antus, Ágnes Zvara, Zoltán Hegedűs, Zsolt Czimmerer and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Function of antigen-presenting cells in non-small-cell lung cancer (NSCLC).Medical oncology (Northwood, London, England) · 2025
    Review
  11. Combined Immune Checkpoint Blockade and HelixorInternational journal of molecular sciences · 2025
    Article
  12. Review
  13. Article
  14. Deciphering the Complexities of Pulmonary Hypertension: The Emergent Role of Single-Cell Omics.American journal of respiratory cell and molecular biology · 2025
    Review
  15. Article
  16. Article
  17. Immune Checkpoint Blockade Combined with AbnobaViscumPharmaceuticals (Basel, Switzerland) · 2024
    Article
  18. Closing Editorial: Immunophenotyping in Autoimmune Diseases and Cancer 3.0.International journal of molecular sciences · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Nikolett GémesLaboratory of Functional Genomics, HUN-REN Biological Research Centre, Szeged, Hungary.
József Á BalogLaboratory of Functional Genomics, HUN-REN Biological Research Centre, Szeged, Hungary.
Patrícia NeupergerLaboratory of Functional Genomics, HUN-REN Biological Research Centre, Szeged, Hungary.
Erzsébet SchleglNational Korányi Institute of Pulmonology, Budapest, Hungary.
Imre BartaNational Korányi Institute of Pulmonology, Budapest, Hungary.
János FillingerNational Korányi Institute of Pulmonology, Budapest, Hungary.
Balázs AntusNational Korányi Institute of Pulmonology, Budapest, Hungary.
Ágnes ZvaraLaboratory of Functional Genomics, HUN-REN Biological Research Centre, Szeged, Hungary.
Zoltán HegedűsLaboratory of Bioinformatics, HUN-REN Biological Research Centre, Szeged, Hungary.
Zsolt CzimmererMacrophage Polarization Group, Institute of Genetics, HUN-REN Biological Research Centre, Szeged, Hungary.
Máté ManczingerSynthetic and Systems Biology Unit, Institute of Biochemistry, HUN-REN Biological Research Centre, Szeged, Hungary.
Gergő Mihály BaloghSynthetic and Systems Biology Unit, Institute of Biochemistry, HUN-REN Biological Research Centre, Szeged, Hungary.
József TóváriNational Institute of Oncology, Budapest, Hungary.
László G Puskás *Laboratory of Functional Genomics, HUN-REN Biological Research Centre, Szeged, Hungary.
Gábor J Szebeni *Laboratory of Functional Genomics, HUN-REN Biological Research Centre, Szeged, Hungary.
University of Szeged · HUHUN-REN Szegedi Biológiai Kutatóközpont · HUOrszágos Korányi Tbc és Pulmonológiai Intézet · HUNational Institute of Oncology · HUUniversity of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Tobacco smoking generates airway inflammation in chronic obstructive pulmonary disease (COPD), and its involvement in the development of lung cancer is still among the leading causes of early death. Therefore, we aimed to have a better understanding of the disbalance in immunoregulation in chronic inflammatory conditions in smoker subjects with stable COPD (stCOPD), exacerbating COPD (exCOPD), or non-small cell lung cancer (NSCLC). Methods: Smoker controls without chronic illness were recruited as controls. Through extensive mapping of single cells, surface receptor quantification was achieved by single-cell mass cytometry (CyTOF) with 29 antibodies. The CyTOF characterized 14 main immune subsets such as CD4+, CD8+, CD4+/CD8+, CD4-/CD8-, and γ/δ T cells and other subsets such as CD4+ or CD8+ NKT cells, NK cells, B cells, plasmablasts, monocytes, CD11c Results: Our focus was on T-cell-dependent differences in COPD and NSCLC, where peripheral CD4+ central memory and CD4+ effector memory cells showed a significant reduction in exCOPD and CD4+ CM showed elevation in NSCLC. The transcriptome analysis delineated a perfect correlation of differentially expressed genes between exacerbating COPD and NSCLC-derived peripheral CD4+ CM or CD4+ EM cells. The measurement of 17 immuno-oncology soluble mediators revealed a disease-associated phenotype in the peripheral blood of stCOPD, exCOPD, and NSCLC patients. Discussion: The applied single-cell mass cytometry, the whole transcriptome profiling of peripheral CD4+ memory cells, and the quantification of 17 plasma mediators provided complex data that may contribute to the understanding of the disbalance in immune homeostasis generated or sustained by tobacco smoking in COPD and NSCLC.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsPulmonary Disease, Chronic ObstructiveCD4-Positive T-LymphocytesHumansImmunophenotypingMemory T CellsCD4 central memory T cellsCD4 effector memory T cellsexacerbating COPDnon-small cell lung cancersingle-cell mass cytometrystable COPDtobacco smoking

Identifiers

PMID38187374
PMCPMC10770259
OpenAlexW4389999862

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.